TGM2 and neoplasm: In contrast to the HME2-parental tumors, treatment of the HME2-BM tumors with neratinib did not significantly affect tumor growth, but depletion of TG2 allowed for a significant inhibition of tumor growth upon neratinib treatment (Fig. 2c-d).